Karius is a life sciences company that envisions a world where infectious diseases are no longer a major threat to the human health. We advance diagnostic science and technology in order to deliver breakthroughs and upgrade the standard of care in the fight against infectious disease.
The Karius Test™ is a liquid biopsy for infectious diseases that can free clinicians from the diagnostic maze so they can return patients back to health quickly and safely. From a single blood sample, the Karius Test can non-invasively and rapidly detect over 1000 pathogens causing both deep-seated and bloodstream infections. The Karius Test helps clinicians avoid invasive, low-yield, and sequential diagnostic tests that can delay treatment for the most vulnerable hospitalized patients.
Karius develops and maintains various components to serve its mission, including but not limited to Bioinformatics analytical methods, NGS sample processing software (Lab Information Management System), customer engagement software (web and mobile), data analytics and reporting platform.